Australia markets closed

Ocuphire Pharma, Inc. (OCUP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.9900+0.1400 (+7.57%)
At close: 04:00PM EDT
1.9400 -0.05 (-2.51%)
After hours: 07:17PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 49.38M
Enterprise value 30.21M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.26
Price/book (mrq)0.99
Enterprise value/revenue 1.59
Enterprise value/EBITDA -3.03

Trading information

Stock price history

Beta (5Y monthly) 0.24
52-week change 3-68.16%
S&P500 52-week change 322.38%
52-week high 36.6000
52-week low 31.5000
50-day moving average 31.9980
200-day moving average 32.9558

Share statistics

Avg vol (3-month) 3227.44k
Avg vol (10-day) 3189.69k
Shares outstanding 524.81M
Implied shares outstanding 624.81M
Float 823.83M
% held by insiders 16.51%
% held by institutions 113.39%
Shares short (15 Apr 2024) 41.58M
Short ratio (15 Apr 2024) 45.74
Short % of float (15 Apr 2024) 46.56%
Short % of shares outstanding (15 Apr 2024) 46.37%
Shares short (prior month 15 Mar 2024) 41.65M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 306 Nov 2020
Ex-dividend date 4N/A
Last split factor 21:4
Last split date 306 Nov 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -52.42%
Operating margin (ttm)-321.05%

Management effectiveness

Return on assets (ttm)-12.83%
Return on equity (ttm)-20.77%

Income statement

Revenue (ttm)19.05M
Revenue per share (ttm)0.88
Quarterly revenue growth (yoy)-95.80%
Gross profit (ttm)N/A
EBITDA -10.56M
Net income avi to common (ttm)-9.99M
Diluted EPS (ttm)-0.4600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)50.52M
Total cash per share (mrq)2.04
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)13.35
Book value per share (mrq)2.08

Cash flow statement

Operating cash flow (ttm)-1.11M
Levered free cash flow (ttm)244.12k